Article Sidebar
Main Article Content
Abstract
There has been much recent heightened interest in the possible use of cannabinoid products in the treatment of complex epilepsies. Although systematic studies have now been performed and reported showing benefit of cannabidiol as Epidiolex (GW Pharma) in the treatment of Dravet and Lennox Gastaut syndromes, there remains much confusion with the role of hemp oils and other products for which there is no consistent product or evidence base for use. There is also much debate as to whether the psychoactive component, tetrahydrocannabinol is required for optimal effect, with no sound evidence base for support. The current position is that that data has been acquired for Epidiolex, and licence for use granted by the Federal Drug Administration, with data submitted to the European Medicines Authority. We await full licence and availability to enable prescription as a further therapeutic option for the complex developmental epileptic encephalopathies.
Keywords
Article Details
Copyright (c) 2019 J Helen Cross
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright in their work and grant the Journal of the International Child Neurology Association (JICNA) the right of first publication. The work is simultaneously licensed under a Creative Commons Attribution–NonCommercial–ShareAlike 4.0 International License (CC BY-NC-SA 4.0).
Under this licence, others may share and adapt the work provided that they:
-
give appropriate credit to the author(s) and acknowledge the work's initial publication in JICNA;
-
do not use the work for commercial purposes; and
-
distribute any adapted material under the same licence.
Authors may enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work, for example, by depositing it in an institutional repository or including it in a book, provided that its initial publication in JICNA is acknowledged.
Authors are permitted and encouraged to post their work online, including in institutional repositories and on personal or institutional websites, prior to and during the submission process, as this may facilitate scholarly exchange and increase the visibility and citation of published work.